438207-93-3Relevant articles and documents
QUINOLYL AMIDE DERIVATIVES AS CCR-5 ANTAGONISTS
-
Page 31, (2010/02/10)
The present invention relates to a series of compounds which are CCR-5 receptor antagonists of the general formula (I): or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein.
Discovery of 4-[(Z)-(4-bromophenyl)(ethoxyimino)methyl]-1′-[(2,4-dimethyl- 3pyridinyl)carbonyl]-4′-methyl-1,4′bipiperidine N-oxide (SCH 351125): An orally bioavailable human CCR5 antagonist for the treatment of HIV infection
Palani,Shapiro,Clader,Greenlee,Cox,Strizki,Endres,Baroudy
, p. 3339 - 3342 (2007/10/03)
Structure - activity studies on piperidino-piperidine 3 led to the discovery of SCH 351125 (1), a selective CCR5 antagonist with potent activity against RANTES binding (Ki=2 nM), which possesses subnanomolar activity in blocking viral entry and